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•  Protein prenylation is a lipid post-translational 
modification in which either a 15-carbon farnesyl or a 
20-carbon geranylgeranyl isoprenoid moiety is linked 
to a specific cysteine residue within a protein. Two 
enzymes, farnesyltransferase or 
geranylgeranyltransferase facilitates prenylation. Two 
percent of proteins in the human genome are 
prenylated, among which include Ras and Rho 
proteins that affect cellular growth and regulation. 
Overexpression of prenylated proteins have been 
related to diseases including cancer, Alzheimer’s, 
fungal infections and malaria. Moreover, 30% of all 
reported cancers are related to mutation within K-Ras 
proteins (Bos et. al, 1991). Due to the fact that many 
prenylated proteins gain their active function after 
being post-transnationally modified, the study of 
controlling these modifications remains important. 
There have been improvements on this subject over 
the last two-decades, however, there is still a need to 
investigate how prenylation regulates the cellular 
function and how it’s catalytic activity can be used as 
a tool to explore other cellular functions. 
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As to date, the Distefano lab has described several 
different analogues that act as substrates for 
farnesyltransferase. Using farnesyltransferase as a tool, 
their lab has been able to append different functionalities 
to proteins through their isoprenoid linkage including 
alkyne, azide, hydrazines, benzophenone, DTAFP, 
diazirine. With these functionalized proteins, they study 
isoprenoid-binding sites through photo-crosslinking and 
append chemical reporters to the prenylome through 
orthogonal chemistry unique to the click reaction and 
oxime chemistry. 
To examine the effectiveness of alkyne containing 
isoprenoid analogues, Hela cells were treated with them. 
In 2007, Distefeno group reported the synthesis of 6, and 
it was used the labeling of specific proteins. It was 
incorporated with proteins. It was the first example of 
successful alkyne containing analogue to be 
incorporated into living cells. When 6 was used for 
labeling, the reaction of interest went ahead successfully, 
however other side reaction followed, and the source 
remains unknown. 
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A new idea comes to address the source of the side reaction. Instead of using 6, 
using 5 was proposed. The difference between 5 & 6 is that, propargyl bromide 
was used in the synthesis of 5, while 4-bromobut-1-yne will be used for the 
synthesis of 6 as shown in scheme 1. This paper reports the attempt synthesis of 
5 as shown in scheme 2. 
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Scheme 1: Alkyne containing Isoprenoid analogues: 
Scheme 2: Proposed synthesis route for 5 
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Compounds 2 & 3 has been successfully been synthesis using those reagents and staring materials shown in scheme 2. TLC plate, 
1H-NMR, and Mass Spec have been utilized to confirm the formation of these compounds. Several attempts has been made to 
synthesis compound 4, unfortunately they have not been successful. Discussion, and experimental section for both compounds 2 & 
3 have been reported in a written report. Discussion for the several attempts to make compound 4 is also including into the written 
report. Below is a link for the report.  
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